Robert Keith Warner

Robert Keith Warner (board member) discloses dealings in 2 companies, chiefly RxSight, Inc. and Inari Medical, Inc. We count 17 filings; the first trade dates from 3 August 2021 and the latest from 3 June 2025.

Both buying and selling appear: 1 purchase worth €590k, against 4 sales worth €1.6M. On balance, insiders were net sellers of €986k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 11 share grants.

The latest filing, published on 4 June 2025, reports a share grant in RxSight, Inc. The clock since the last published purchase (5 August 2021) now reads 1,905 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.